Global health social technologies: Reflections on evolving theories and landscapes

Research Policy

Volumn 39, Issue 10, 2010, Pages 1277-1288

  Chataway, Joanna ^a,b   Hanlin, Rebecca ^b   Mugwagwa, Julius ^b   Muraguri, Lois ^b  

^a RAND CORPORATION   (United States)

^b OPEN UNIVERSITY   (United Kingdom)

Author keywords

Global health initiatives; Neglected diseases; Product development partnerships; Social technology

Indexed keywords

AIDS VACCINE; COMPLEX DYNAMICS; CONCEPTUAL FRAMEWORKS; DEVELOPMENT PARTNERSHIPS; GLOBAL HEALTH; MALARIA VACCINE; NEGLECTED DISEASE; PRODUCT DEVELOPMENT PARTNERSHIPS; PUBLIC PRIVATE PARTNERSHIPS; SOCIAL TECHNOLOGY; TECHNOLOGY EXPERIMENTS; THEORETICAL APPROACH; THROUGH THE LENS;

HEALTH; MERGERS AND ACQUISITIONS; PRODUCT DEVELOPMENT; SOCIETIES AND INSTITUTIONS;

TECHNOLOGY;

EID: 78149466873     PISSN: 00487333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.respol.2010.07.006     Document Type: Article

References (50)

1. P. Bejon, J. Lusingu, A. Olotu, A. Leach, M. Lievens, J. Vekemans, S. Mshamu, T. Lang, J. Gould, M.C. Dubois, M.A. Demoitie, J.F. Stallaert, P. Vansadia, T. Carter, P. Njuguna, K.O. Awuondo, A. Malabeja, O. Abdul, S. Gesase, N. Mture, C.J. Drakeley, B. Savarese, T. Villafana, W.R. Ballou, J. Cohen, E.M. Riley, M.M. Lemnge, K. Marsh, and L. von Seidlein Efficacy of RST, S/AS01E vaccine against malaria in children 5 to 17 months of age New England Journal of Medicine 359 2008 2521
2. Bell, M., 2007. Technological learning and the development of production and innovative capacities in the industry and infrastructure sectors of least developed countries. What role for ODA? Background Paper No. 10 to UNCTAD's Least Developed Countries Report 2007. UNCTAD, Geneva.
3. G. Bowker, and S.L. Star Sorting Things Out: Classifications and its Consequences 1999 Cambridge, MA MIT Press
4. D. Brinkerhoff, and M. Brinkerhoff Partnerships between international donors and non-governmental development organisations: opportunities and constraints International Review of Administrative Sciences 70 2 2004 253 270
5. S. Brusoni, A. Prencipe, and K. Pavitt Knowledge specialization, organizational coupling, and the boundaries of the firm: why do firms know more than they make? Administrative Science Quarterly 46 4 2001 597 621
6. M.A. Burke, and S.A. Matlin Monitoring Financial Flows for Health Research 2008: Prioritizing Research for Health Equity 2008 Global Forum for Health Research Geneva
7. K. Buse, and G. Walt Global public-private partnerships: Part I: a new development in health? Bulletin of the World Health Organization 8 4 2000 549 561
8. J. Chataway, D. Wield, R. Hanlin, J. Mugwagwa, J. Smith, and K. Chaturvedi Building the case for systems of health innovation in Africa F.A. Kalua, A. Awotedu, L.A. Kamwanja, J.D.K. Saka, Science, Technology and Innovation for Public Health in Africa 2009 NEPAD Office of Science and Technology Pretoria
9. J. Chataway, D. Wield, R. Hanlin, J. Mugwagwa, J. Smith, and K. Chaturvedi Technological trends and opportunities to combat diseases of the poor in Africa F.A. Kalua, A. Awotedu, L.A. Kamwanja, J.D.K. Saka, Science, Technology and Innovation for Public Health in Africa 2009 NEPAD Office of Science and Technology Pretoria
10. J. Chataway, S. Brusoni, E. Cacciatori, R. Hanlin, and L. Orsenigo The International AIDS Vaccine Initiative (IAVI) in a changing landscape of vaccine development: a public private partnership as knowledge broker and integrator European Journal of Development Research 19 1 2007 100 117
11. J. Chataway, and J. Smith The International AIDS Vaccine Initiative (IAVI): innovation driven by communication IDS Bulletin 38 5 2007 74 82
12. J.C. Chataway, and J. Smith The International AIDS Vaccine Initiative (IAVI): is it getting new science and technology to the world's neglected majority? World Development 34 1 2006 16 30
13. N. Clark The Political Economy of Science and Technology 1985 Blackwell Oxford
14. N. Clark Public-Private Partnerships in the Biotechnology Sector 2000 Scottish Universities Policy Research and Advice (SUPRA) (Paper no. 12)
15. Cockburn, I.M., Henderson, R., Stern, S., 1999. The diffusion of science driven drug discovery: organisational change in pharmaceutical research. NBER Working Paper, No. W7359.
16. I.M. Cockburn, and R.M. Henderson Absorptive capacity, coauthoring behavior, and the organization of research in drug discovery Journal of Industrial Economics 46 2 1998 157 182
17. P. Dimaggio Culture and cognition Annual Review of Sociology 23 1997 263 287
18. C. Elias Can we ensure health is within reach for everyone? Lancet 368 2006 S40 S41
19. Feuer, C., et al., 2009. Adapting to realities: trends in HIV prevention research funding 2000 to 2008. HIV Vaccine and Microbicides Resource Tracking Working Group, www.hivresourcetracking.org (accessed 10 January 2010).
20. D.K. Foley Adam's Fallacy: A Guide to Economic Theology 2006 The Belknap Press of Harvard University Press, Cambridge University Press London
21. N. Forbes, and D. Wield From Followers to Leaders: Managing Technology and Innovation 2002 Routledge London/New York
22. L. Galambos, and J. Sturchio Pharmaceutical firms and the transition to biotechnology: a study in strategic innovation Business History Review 72 1998 250 278
23. A. Gambardella Science and Innovation in the US Pharmaceutical Industry 1995 Cambridge University Press Cambridge
24. M. Gibbons, C. Limoges, H. Nowotny, S. Schwartzman, P. Scott, and M. Trow The New Production of Knowledge: The Dynamics of Science and Research in Contemporary Societies 1994 Sage London
25. A. Hargadon, and R.I. Sutton Technology brokering and innovation in a product development firm Administrative Science Quarterly 42 4 1997 716 749
26. R. Henderson, L. Orsenigo, and G. Pisano The pharmaceutical industry and the revolution in molecular biology: interactions among scientific, institutional and organisational change D. Mowery, R. Nelson, Sources of Industrial Leadership: Studies of Seven Industries 1997 Cambridge University Press Cambridge
27. A.O. Hirschman Exit, Voice and Loyalty: Responses to Decline in Firms, Organisations and States 1970 Harvard University Press Cambridge, MA/London
28. A.O. Hirschman The Strategy of Economic Development 1958 Yale University Press
29. IAVI Press Release Mayor Bloomberg and Other Honourees Herald Opening of IAVI's New Design Lab. IAVI Press Release 2008 IAVI New York http://www.iavi.org/viewfile.cfm?fid=49836 (accessed 15 March 2009)
30. IAVI Imagine a World without AIDS: The History of the International AIDS Vaccine Initiative 2006 IAVI New York
31. IAVI, 2004. IAVI Annual Progress Report. IAVI, New York.
32. R. Kaplinsky The Economies Small: Appropriate Technology in a Changing World 1990 Intermediate Technology Press London
33. H.E. Kettler, and A. Towse Public Private Partnerships for Research and Development: Medicines and Vaccines for Diseases of Poverty 2002 Office of Health Economics London
34. K. Knorr-Certina, and A. Cicourel Advances in Social Theory and Methodology: Toward and Integration of Micro- and Macro-sociologies 1981 Routledge Boston
35. B. Latour Reassembling the Social: An Introduction to Actor-Network-Theory 2005 Oxford University Press Oxford
36. Lob-Levyt, J., 2008. Delivering the promise through new markets, new money and new partnerships for development. Statement by Executive Secretary, GAVI Alliance, available at http://www.gavialliance.org/media-centre/statements/ 2008-04-10-en-promise.php (accessed 27 June 2010).
37. R. Mazzoleni, and R.R. Nelson Public research institutions and economic catch-up Research Policy 36 2007 1512 1528
38. J.S. Metcalfe, and R. Ramlogan Innovation systems and the competitive process in developing economies The Quarterly Review of Economics and Finance 48 2008 433 446
39. M. Moran, A. Ropars, J. Guzman, J. Diaz, and C. Garrison The New Landscape of Neglected Disease Drug Development 2005 Wellcome Trust, London School of Economics and Political Science London
40. G. Myrdal Economic Theory and Underdeveloped Regions 1957 Princeton University Press
41. R.R. Nelson What enables rapid economic progress: what are the needed institutions? Research Policy 37 1 2008 1 11
42. R.R. Nelson, and B.N. Sampat Making sense of institutions as a factor shaping economic performance Journal of Economic Behavior and Organization 44 2001 31 54
43. L. Orsenigo, S. Brusoni, and E. Cacciatori Beyond market failures: IAVI and the organizational challenges of vaccine development S. Matlin, L. Sundaram, M. Gehner, Health Partnerships Review 2008 Global Forum for Health Research Geneva
44. T. Papaioannou, D. Wield, and J.C. Chataway Knowledge ecologies and ecosystems? An empirically grounded reflection on recent developments in innovation systems theory The 6th International Triple Helix Conference on University-Government-Industry Relations 16-18 May 2007, Singapore 2007
45. D. Rodrik Industrial Policy for the Twenty-First century 2004 John F. Kennedy School of Government Cambridge, MA
46. M. Saad, K. Rowe, and P. James Developing and sustaining effective partnerships through a high level of trust L. Montanheiro, Public and Private Sector Partnerships: Furthering Development 1999 SHU Press Sheffield
47. Skolnik, R., 2003. An independent evaluation of the International AIDS Vaccine Initiative (IAVI). April. Available on the IAVI website: www.iavi.org.
48. S.L. Star, and J.R. Griesemer Institutional ecology, 'translations', and boundary objects: amateurs and professionals in Berkley's Museum of Vertebrate Zoology Social Studies of Science 19 1989 387 420
49. J. Tait, D. Wield, A. Bruce, and J. Chataway OECD International Futures Project on the Bioeconomy to 2030: Designing a Policy Agenda. Health Biotechnology to 2030 2007 OECD Paris
50. D. Vaughan Signals and interpretive work: the role of culture in a theory of practical action Karen Cerulo Culture in Mind: Toward a Sociology of Culture and Cognition 2002 Routledge New York